| Model Number |
9735542 |
| Medical Device Problem Code |
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/22/2021
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
Medtronic received information regarding a thermal therapy system being used for a neuro soft tissue ablation procedure.It was reported that during a case, the laser fiber was implanted with no issues in the operating room (or).A cyst that was right next to the tumor that was being ablated was drained of ~88 cc fluid in the or.The patient was then brought to magnetic resonance imaging (mri) to set up for the ablation.Once started, they noticed that the area being the cyst was starting to heat up, as if the heat was crossing over the air in the free space where the cyst had been aspirated.The temperature in this area was changing values.This occurred in multiple ablation, as they were performing pull-backs.Even when they had let the area cool down on one of the pull backs, in that one area, it was showing that the temperature was high.This caused no delay and no patient impact.
|
| |
|
Additional Manufacturer Narrative
|
|
Concomitant medical products: other relevant device(s) are: product id: m450001b022, software version 3.3.2.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Additional Manufacturer Narrative
|
|
H3: a software investigation analysis was initiated to determine the probable cause of the issue through log analysis.Analysis found that software was functioning as designed.There was not enough pre-scan magnetic field homogenization performed on the magnetic resonance imaging (mri) side.The ablation sessions exceeded the recommended time.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Additional Manufacturer Narrative
|
|
Software files have been received by the manufacturer.However, analysis has not been completed at the time of filing.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|